Several studies have demonstrated that plasma LPL mass concentration could be altered by drug manipulations, such as fibrate, insulin sensitizer, and statins in patients with diabetes, potentially affecting the progression of their atherosclerosis [4–6]. Here, LPL is linked to atherosclerosis.